ECSP961635A - CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING - Google Patents

CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Info

Publication number
ECSP961635A
ECSP961635A ECSP961635A ECSP961635A EC SP961635 A ECSP961635 A EC SP961635A EC SP961635 A ECSP961635 A EC SP961635A EC SP961635 A ECSP961635 A EC SP961635A
Authority
EC
Ecuador
Prior art keywords
steroids
controlled release
sugar coating
sugar
steroid
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Barcomb Joseph Reginald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961635 priority Critical patent/ECSP961635A/en
Publication of ECSP961635A publication Critical patent/ECSP961635A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición con recubrimiento de azúcar para la aplicación a una tableta medical comprimida, compuesta de azúcar una dosificación de un esteroide hormonal y un porcentaje de desprendimiento de esteroide que controle la cantidad de celulosa microcristalina.The present invention relates to a sugar-coated composition for application to a compressed medical tablet, composed of sugar, a dosage of a hormonal steroid and a percentage of steroid release that controls the amount of microcrystalline cellulose.

ECSP961635 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING ECSP961635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Publications (1)

Publication Number Publication Date
ECSP961635A true ECSP961635A (en) 1997-06-27

Family

ID=42042369

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Country Status (1)

Country Link
EC (1) ECSP961635A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US11957684B2 (en) 2016-09-30 2024-04-16 Sumitomo Pharma Switzerland Gmbh Treatment of heavy menstrual bleeding associated with uterine fibroids
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Similar Documents

Publication Publication Date Title
AR002019A1 (en) A SUGAR COATING COMPOSITION FOR APPLICATION TO A COMPRESSED MEDICINAL TABLET AND A COMPRESSED TABLET.
ES2179165T3 (en) CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGS.
EP1319404A3 (en) Composition for treating and/or prophylaxis of tumors of the breast
ES2174629T3 (en) 14,15-CYCLOPROPAN-STEROIDS OF THE 19-NOR-ANDROSTAN SERIES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE COMPOUNDS.
NO20092730L (en) Selective estrogen receptor modulator in combination with dehydroeiandrosterone (DHEA) or analogues
ATE493132T1 (en) MEDICINAL PRODUCTS COMPRISING AT LEAST ONE PROGESGEN
WO1998027929A3 (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
NO964089L (en) Pharmaceutical combination preparation for hormonal contraception
PL324552A1 (en) Plaster for pecutaneous administration of hormones
BR0014569A (en) Pattern-coated adhesive article, method for forming an adhesive article and method for facilitating wound healing
AR009407A1 (en) USE OF PROGESTERONE TO PREPARE A PHARMACEUTICAL COMPOSITION USEFUL TO TREAT OR REDUCE ISCHEMIA AND / OR A CORONARY ARTERIAL DISEASE AND / OR THE INCIDENCE OF CARDIOVASCULAR EVENTS
NO976067L (en) Pharmaceutical combination preparation, kits and method of hormonal contraception
PL342486A1 (en) Application of extracts from iris and cimicifuga racemosa plants as an oestrogenoidic organoselective therapeutic agents without utherothropic action
ES2172592T3 (en) PROGESTERONE ANTAGONIST AGENT AND GESTAGEN AGENT FOR THE TREATMENT OF ENDOMETRIOSIS AND UTERINE LIOMIOMA.
DE122007000011I1 (en) Solid dosage forms containing clathrates of the steroidal sex hormone ethinyl estradiol
BG104397A (en) Extended release formulation
ECSP961635A (en) CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING
DK0871453T3 (en) Pharmaceutical combination hormone contraceptive
AU6367496A (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
WO2000037109A3 (en) Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
NO990498L (en) 19-nor-cholansteroids as neurochemical initiators of change in human hypothalamic function
WO2002074315A8 (en) Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
BR9814136A (en) Contraceptive set, manufacturing processes and bleeding treatment, uses of anti-progestin, progestin and anti-progestin, and a compound.
DOP2023000029A (en) NEW COMPOSITION OF MODIFIED RELEASE ORAL CONTRACEPTIVE
Whitehead Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data